从 niche 到 norm:弥合差距并主流化递增式血液透析的多行动方案
递增式血液透析以患者临床需求为先,从每周1或2次开始,依据残余肾功能和临床状况逐步调整频率和/或时长;观察性研究和试点试验显示其临床结局不劣于每周3次起始的标准方案,部分中心已将其作为常规照护;本文不规定具体方法,而是描述当前实践,并基于实施研究综合框架提出个体、组织与系统层面的可行动项以促进推广。
要点
- 递增式血液透析从每周1或2次起始,根据患者临床状况逐步增加频率和/或时长。
- 观察性研究和试点试验显示,递增式起始的临床结局不劣于每周3次起始的标准方案。
- 部分中心已将递增式血液透析作为常规照护,多数中心仍不论患者个体特征一律采用每周3次方案。
核心结论
- 递增式血液透析以患者临床需求为先,而非以透析尿素清除等刚性指标为先。
- 观察性研究和试点试验显示递增式起始的临床结局不劣于每周3次起始的标准方案。
- 本文不规定具体方法,而是描述当前递增式血液透析实践,并提出可行动项以促进其成为可及的患者中心选项。
研究设计与样本
- 本文为叙述性文章,不规定具体方法,而是描述当前递增式血液透析实践。
- 借鉴实施研究综合框架,识别个体、组织与系统层面需发展的基础因素。
- 提出可行动项以促进递增式血液透析更广泛实施。
主要发现
- 递增式血液透析从每周1或2次开始,依据患者临床状况逐步增加频率和/或时长。
- 尿毒症相关临床表现通过残余肾功能、透析、饮食调整和药物综合管理。
- 治疗充分性通过临床评估、血液检查及残余肾功能测量来评价。
- 许多观察性研究和若干试点试验显示递增式起始的临床结局不劣于每周3次起始的标准方案。
- 部分中心已将递增式血液透析作为常规照护,多数中心仍不论患者个体特征一律采用每周3次方案。
关键数值与推荐
- 递增式起始以每周1或2次开始,依据患者临床状况逐步增加频率和/或时长。
- 治疗充分性评价包括临床评估、血液检查和残余肾功能测量。
- 尿毒症相关临床表现通过残余肾功能、透析、饮食调整和药物综合管理。
临床怎么用
- 本文不规定具体方法,而是描述当前递增式血液透析实践。
- 部分中心已将递增式血液透析作为常规照护,多数中心仍不论患者个体特征一律采用每周3次方案。
- 作者提出可行动项以促进递增式血液透析成为可及的患者中心选项。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Attention is increasingly turning toward the individualization of hemodialysis prescriptions through an incremental start. This approach prioritizes the patient's clinical needs over rigid metrics like dialysis urea depuration, begins with fewer sessions (1 or 2 per week), and gradually increases in frequency and/or duration based on the patient's evolving clinical condition. Clinical manifestations related to uremia are managed through a combination of residual kidney function, dialysis, dietary modification, and medications. Treatment adequacy is evaluated using clinical assessment, blood tests, and measurement of residual kidney function. Many observational studies and a number of pilot trials have shown that clinical outcomes with incremental-start hemodialysis are not inferior to the standard approach of hemodialysis initiation with 3 sessions per week. Consequently, some centers have adopted incremental-start hemodialysis as routine care. However, most centers apply the standardized practice of thrice-weekly hemodialysis as soon as dialysis is introduced in patient care and afterward, regardless of the patient's individual characteristics. This article does not prescribe a specific approach but rather describes the current practice of incremental-start hemodialysis. We seek to advance the practice of incremental-start hemodialysis by addressing critical gaps in knowledge, practice models, and supportive infrastructure with a view to more widespread implementation. Drawing on the Consolidated Framework for Implementation Research, we identify foundational factors at individual, organizational, and systemic levels that need development to facilitate broader adoption. Finally, we propose actionable items to ensure that incremental-start hemodialysis becomes a viable, patient-centered option accessible to all who might benefit.
引用
- Murea M, Torreggiani M, Deira J, et al. From niche to norm: a multiaction plan to close gaps and mainstream incremental hemodialysis. Kidney Int. 2025. PMID: 40403930. doi:10.1016/j.kint.2025.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。